All IndicationsOncology
🎗️
Advanced EGFR-mutated NSCLC
1
Companies
1
Drug Programs
0
Phase 3
0
Upcoming PDUFAs
Competitors
| Company | Drug | Phase | Designations | Timeline | Trial ID |
|---|---|---|---|---|---|
| KAPA Kairos Pharma | ENV-105 | Phase 1 | — | — | — |
Development Stage Distribution
Phase 1
1
PDUFA Timeline
No upcoming PDUFA dates for this indication.
Not financial advice
Signals are probabilistic and based on historical data — past performance doesn't guarantee future results. Do your own research.
